And divarasib reduced the risk for death by 44% during the trial, with a median overall survival (OS) of 17.7 versus 12 ...
Lenovo's Googlebook 15 is a lackluster laptop paired with a Googlebook operating system that doesn't feel particularly useful ...
Explore the top 15 smart home companies revolutionizing connectivity in residential ecosystems and enhancing your home ...
As a cornerstone of Merck & Co.’s post-Keytruda oncology strategy, sac-TMT has cleared a clinical milestone. | As a ...
"Employees might be pasting internal documents into external AI services based on their own judgment." As the use of AI ...
TMT, has shown a strong tumor progression benefit in first-line, PD-L1-negative non-small cell lung cancer in a China phase 3 ...
Beyond MSD and Moderna’s melanoma vaccine, other notable skin cancer data were shared at ESMO 2026.
Updated Results of GPC3-Targeted Armored CAR-T Therapy in Advanced HCC / cancer, Cancer research, cancer treatment, CAR ...
MedPage Today on MSN
Novel HDAC Inhibitor Hits Main Goal in Unresectable Melanoma Trial
Four-month gain in PFS with HBI-8000, 13 months in LDH-normal subgroup, but toxicity a con ...
Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, ...
The next-generation KRAS G12C inhibitor divarasib significantly prolonged progression-free survival (PFS) and overall ...
HPE patched multiple Aruba Networking flaws that could allow attackers to take full control of affected AOS-8 and AOS-10 devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results